StockWatch
·

Mach Conferences And Events Ltd Q2 FY27 Results

MACHLTDQ2 FY27 Results
Filing
MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue204.5341.7%110.7%
Total Income205.7340.5%108.5%
Expenditure193.0839.8%118.3%
PBT12.6553.6%23.8%
Net Profit9.2650.9%18.4%
OPM—
NPM4.50%0.31pp3.43pp
EPS4.40
View full financials
MACH CONFERENCES AND EVENTS · Q2 FY27 · THE VERDICT

Revenue Doubled, But Profit Growth Stalled — Margin Collapse Threatens IPO Timeline

Mach delivered record revenue growth of 110.7% YoY, but reported profit lagged far behind. The real story: management overstated growth rates on the call, and a 5x team expansion has created a fixed cost base that isn't generating profit leverage.

16 Nov 2026 · 6 min read

On the surface, a blowout quarter: revenue doubled year-over-year to ₹204.5 crore, and Mach is tracking towards its ₹500+ crore FY27 target. But beneath that headline lies a profitability story that should concern anyone watching the IPO clock. Profit grew only 18.4% — a fraction of the revenue growth — and management's on-call claims don't square with the delivered result. The culprit is a wage bill that has exploded from rapid hiring, leaving margins halved and the path to profitability obscured.

Revenue YoY

+110.7%

₹204.5 Cr vs implied ₹97.1 Cr

PAT YoY

+18.4%

₹9.3 Cr vs implied ₹7.85 Cr

Growth gap

6x divergence

Revenue +110% | PAT +18%

EBITDA margin

7%

Down 580 bps from 12.81%

The claims that don't hold up

Management's on-call statements vs. delivered result
What management statedDelivered resultVerdict
Revenue growth 174.7% (204.53 Cr vs 74.46 Cr prior year)Revenue growth 110.7% (₹204.5 Cr vs ~₹97.1 Cr prior year)Contradicted — 64 percentage point overstatement
PAT growth 47% (9.26 Cr vs 6.3 Cr prior year)PAT growth 18.4% (₹9.3 Cr vs ~₹7.85 Cr prior year)Contradicted — 28.6 percentage point overstatement
EBITDA margin 7% in Q2EBITDA ₹14.39 Cr on ₹204.5 Cr revenue = 7.0% marginSupported
140+ corporate clients onboarded140+ corporate clients confirmed in portfolioSupported

The revenue discrepancy is striking: the CFO used ₹74.46 crore as the prior-year base, but the delivered result implies a prior-year Q2 revenue of roughly ₹97 crore. Same issue with PAT: the call used ₹6.3 crore as the prior-year PAT, but delivered implies ₹7.85 crore. These aren't rounding errors — they're material misstatements that inflated both growth rates. The net effect: management claimed hypergrowth (174.7% revenue, 47% PAT) when the actuals are strong but more measured (110.7% revenue, 18.4% PAT). This matters because it raises a credibility flag for forward guidance.

Where the profit got left behind

Revenue +110.7% YoY, but PAT +18.4% — a 6x divergence. The culprit is straightforward: wage costs. In Q2 alone, wage and employee benefit costs surged to ₹10.45 crore from ₹3.36 crore in the prior year, a 211% increase. This happened because headcount expanded from 70–90 to 350 in just 6 months — a 5x jump. Management's frame: "The 350 team members will take time to bring in business... we are aggressive in the market in acquiring business and we have compromised on our PAT margins." But the issue isn't margin "compromise" — it's that the cost base has ossified at a level that doesn't generate profit leverage. Revenue can grow, but profitability won't catch up until either (a) new employees are productive, or (b) payroll spending stabilizes and flattens against growing revenue. Neither has shown up yet.

EBITDA margin (% of revenue)
04.789.5614.357Q2 FY2712.81Q2 FY2612.5Historical target
Margin compression in one quarter: EBITDA fell 580 basis points YoY, driven entirely by wage inflation.

What changed this quarter

  • FY27 revenue target reframed as 2.5x FY26 (explicit multiplier, maintaining ₹500+ Cr)

  • Team expanded from 70–90 to 350 in 6 months; cost base now described as 'in place'

  • Margin recovery timeline remains opaque ('slowly and steadily' — no quantified target or deadline)

  • Corporate clients grew to 140+; one long-term customer (8–9 years) signed SBT booking tool contract

  • Government/institutional business now 15–20% of revenue; Yatra program with payment delays being resolved

  • B2C platform (Machtravel.com, Mach Travel app) launched public beta Aug 31; immaterial to revenue, commercialization vague

How the street is positioned

The stock is trading at ₹206.05, down 34.4% from its all-time high of ₹314 — a meaningful drawdown that reflects market skepticism. Technically, it sits above its 50- and 200-day moving averages (₹200.9 and ₹152.3, respectively), suggesting some support, but below the 20-day average of ₹221.6, indicating recent weakness. RSI at 45.2 signals a neutral zone — not oversold, not overbought.

Ownership tells a story: FII ownership fell to 3.03% from 3.21% last quarter (net selling), and DII ownership dropped to 1.45% from 1.96% (also selling). Meanwhile, promoter stakes climbed to 74.83% from 72.93% — a net 1.9 percentage point accumulation. This divergence is telling: external institutions are trimming exposure while the founder is buying dips. It suggests insider conviction in the long-term strategy (IPO, profitability recovery) but limited confidence from the market on near-term execution. The sharp drawdown and FII/DII selling align with the fundamental story: margin compression is real, profitability scaling is in doubt, and the IPO timeline may be at risk if turnaround doesn't show up in Q3.

The bull-bear ledger

What's working
  • Revenue trajectory strong: 110.7% YoY, tracking towards 2.5x FY26 target (H1 is 70% of full-year goal)

  • Diversification into 6 verticals (MICE, corporate travel, government, leisure, B2C, inbound) de-risks MICE concentration

  • Corporate travel segment gaining traction: 140+ clients, SBT booking tool cross-sell hook alive

  • Government business opening new channel (Yatra, state contracts, 15–20% of Q2 revenue)

  • IPO catalyst ~10 months away provides exit liquidity and growth capital

  • MICE industry secular tailwind: corporate events, employee wellness travel rebounding post-COVID

What's broken
  • Profitability scaling failed: PAT +18.4% on revenue +110.7% signals cost structure is broken

  • Margin halved in one quarter: EBITDA 7% vs 12.81% prior year (−580 bps) with no recovery timeline given

  • Team overexpanded: 70→350 in 6 months creates fixed cost base with limited flexibility

  • Wage cost spike 211% (₹10.45 Cr Q2 vs ₹3.36 Cr prior) with no cost discipline or efficiency initiatives signaled

  • Management credibility dented: overstated growth rates on call (174.7% vs 110.7% revenue, 47% vs 18.4% PAT)

  • IPO risk: if profitability doesn't stabilize, IPO may slip or reprice down; market less forgiving for unprofitable/improving IPOs

  • New verticals immature: B2C platform in beta with vague commercialization, inbound travel 71 travelers to date

  • Government payment cycles risk: Yatra delays noted Oct–Nov; if collections slip, working capital pressure spikes

Risks, ranked by holder impact

What could go wrong, in order of urgency for a shareholder

Profitability scaling doesn't recover in Q3–Q4

HIGH

If PAT continues to lag revenue growth (e.g., PAT +15% while revenue +25%), margin recovery is off the table for the year. IPO pricing becomes a problem; retail investors expect improving profitability, not deteriorating. Stock could re-rate down sharply.

Wage costs don't stabilize; hiring continues at current run-rate

HIGH

If Q3 wage costs remain above ₹10 Cr (Q2 level), the fixed cost base is too high. No operating leverage until revenue grows faster than headcount. Margins stay compressed for another year or more.

IPO gets delayed or postponed due to profitability concerns

HIGH

Founder is in control (74.83% ownership); IPO is exit catalyst for external shareholders. If IPO slips, liquidity is delayed indefinitely. Stock may gap down on disappointment.

Government segment payment cycles deteriorate further

MEDIUM

Yatra delays Oct–Nov suggest vulnerability. If Nov–Dec recovery doesn't materialize or if other government contracts slow, working capital pressure spikes. Could force borrowing and push interest costs higher (already ₹1.8 Cr in H1).

B2C platform drain (no revenue, rising costs)

MEDIUM

Machtravel.com and Mach Travel app are still in beta with no metrics disclosed. If they require ongoing investment without clear commercialization, they become a cash drain. Investors will demand transparency or shutdown.

Inbound travel fails to scale beyond 71 travelers

MEDIUM

At 71 international travelers, inbound is immaterial. If it doesn't reach 1,000+ travelers by end FY27, the diversification bet looks weaker. Management cited 25% YoY growth, but hitting that requires 3x traffic; unproven.

The debate

What to watch next

Three things that resolve the debate by Q3
  • 1 · Q3 PAT growth vs revenue growth

    The make-or-break metric. If PAT grows >25% (tracking revenue) or wage costs as % of revenue decline, the team expansion thesis is vindicated. If PAT grows 25%, margin compression accelerates and profitability scaling is in trouble. This number determines IPO credibility.

  • 2 · Wage cost run-rate stabilization

    Q2 was ₹10.45 Cr (211% higher than prior year). Q3 must show either (a) flat wages despite higher revenue (productivity inflection), or (b) wages declining as % of revenue. If Q3 wages spike again above ₹10 Cr, the fixed cost base is too high and margin recovery is 2+ years away.

  • 3 · Government business payment recovery + B2C progress

    Yatra program delays in Oct–Nov are being resolved (management said Nov–Dec recovery expected). If Nov–Dec collections materialize, working capital pressure eases. On B2C: any user registration, booking, or revenue figures disclosed would validate the platform bet; silence suggests immateriality or problems.

Mach is a real growth story with topline momentum tracking towards guidance. But the profit quality story is broken. Management overstated metrics on the call, raising credibility concerns. Margin compression is deeper than guided, and the path to recovery is obscure. The IPO is the catalyst, but the clock is ticking: if profitability doesn't inflect by end of Q3, the 10-month IPO window becomes a liability, not an asset.

The organic number to track from here: PAT growth relative to revenue growth. For every 1% of revenue growth, PAT should grow at least 0.8–0.9x in a maturing business. Currently, it's 0.17x (18.4% PAT on 110.7% revenue). If Q3 doesn't show that ratio improving materially, the profitability scaling risk is real, and the stock has further to fall.

Informational and educational content only. Not investment advice.